FindTrial
Sign In

Agreement between transcutaneous and serum bilirubin in infants =35 weeks POG

STUDY OF AGREEMENT BETWEEN TRANSCUTANEOUS AND SERUM BILIRUBIN MEASUREMENTS IN INDIAN INFANTS BORN MORE THAN OR EQUAL TO 35 WEEKS POST MENSTRUAL AGE BEFORE, DURING AND AFTER PHOTOTHERAPY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065826
Enrollment
397
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K768- Other specified diseases of liver

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

COMMAND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Infants born at = 35 weeks POG with clinical hyperbilirubinemia with Transcutaneous bilirbin within 3mg/dl of phototherapy range as per Bhutani chart 2022

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
to determine the agreement between transcutaneous and serum bilirubin measurements before, during (under patch) and after phototherapyTimepoint: before starting phototherapy During- after 24 hours of start of phototherapy After- after 12-24 hours of stopping phototherapy—

Secondary

MeasureTime frame
to discern the difference in Transcutaneous and serum bilirubin readings by sites of assay of TcB, to see the correlation between transcutaneous bilirubin and duration of phototherapy, to explore the accuracy and performance of transcutaneous bilirubinometer for the screening of jaundice in late preterm and term infantsTimepoint: before, during and after phototherapy—

Countries

India

Contacts

Public ContactPriyanka R

Command Hospital Airforce Bangalore

priyankarajendranmbbs@gmail.com8754727546

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026